Baek, S.-H.; Shim, B.-J.; Won, H.; Lee, S.; Lee, Y.K.; Park, H.S.; Kim, S.-Y.
Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial. Pharmaceuticals 2024, 17, 1366.
https://doi.org/10.3390/ph17101366
AMA Style
Baek S-H, Shim B-J, Won H, Lee S, Lee YK, Park HS, Kim S-Y.
Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial. Pharmaceuticals. 2024; 17(10):1366.
https://doi.org/10.3390/ph17101366
Chicago/Turabian Style
Baek, Seung-Hoon, Bum-Jin Shim, Heejae Won, Sunray Lee, Yeon Kyung Lee, Hyun Sook Park, and Shin-Yoon Kim.
2024. "Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial" Pharmaceuticals 17, no. 10: 1366.
https://doi.org/10.3390/ph17101366
APA Style
Baek, S.-H., Shim, B.-J., Won, H., Lee, S., Lee, Y. K., Park, H. S., & Kim, S.-Y.
(2024). Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial. Pharmaceuticals, 17(10), 1366.
https://doi.org/10.3390/ph17101366
